Henry Schein PE Ratio 2006-2021 | HSIC

Current and historical p/e ratio for Henry Schein (HSIC) from 2006 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Henry Schein PE ratio as of June 11, 2021 is 24.03.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Henry Schein PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-06-11 78.90 25.70
2021-03-31 69.24 $3.07 22.55
2020-12-31 66.86 $2.82 23.71
2020-09-30 58.78 $4.06 14.48
2020-06-30 58.39 $4.02 14.52
2020-03-31 50.52 $4.87 10.37
2019-12-31 66.72 $4.69 14.23
2019-09-30 63.50 $3.32 19.13
2019-06-30 69.90 $3.16 22.12
2019-03-31 60.11 $3.31 18.16
2018-12-31 78.52 $3.49 22.50
2018-09-30 85.03 $2.56 33.21
2018-06-30 72.64 $2.64 27.52
2018-03-31 67.21 $2.58 26.10
2017-12-31 69.88 $2.55 27.46
2017-09-30 81.99 $3.47 23.63
2017-06-30 91.51 $3.42 26.80
2017-03-31 84.99 $3.29 25.83
2016-12-31 75.86 $3.10 24.51
2016-09-30 81.49 $3.01 27.07
2016-06-30 88.40 $2.96 29.92
2016-03-31 86.32 $2.93 29.51
2015-12-31 79.10 $2.85 27.75
2015-09-30 66.36 $2.85 23.28
2015-06-30 71.06 $2.76 25.75
2015-03-31 69.81 $2.74 25.52
2014-12-31 68.08 $2.72 25.07
2014-09-30 58.24 $2.65 21.98
2014-06-30 59.33 $2.60 22.86
2014-03-31 59.69 $2.54 23.54
2013-12-31 57.13 $2.46 23.22
2013-09-30 51.88 $2.38 21.85
2013-06-30 47.87 $2.30 20.81
2013-03-31 46.28 $2.23 20.80
2012-12-31 40.21 $2.16 18.66
2012-09-30 39.61 $2.10 18.86
2012-06-30 39.25 $2.06 19.10
2012-03-31 37.84 $2.02 18.73
2011-12-31 32.22 $1.99 16.23
2011-09-30 31.01 $1.91 16.23
2011-06-30 35.80 $1.89 18.99
2011-03-31 35.09 $1.83 19.17
2010-12-31 30.70 $1.75 17.54
2010-09-30 29.29 $1.72 17.03
2010-06-30 27.45 $1.78 15.46
2010-03-31 29.45 $1.73 17.02
2009-12-31 26.30 $1.71 15.43
2009-09-30 27.46 $1.56 17.66
2009-06-30 23.98 $1.41 17.06
2009-03-31 20.00 $1.36 14.76
2008-12-31 18.35 $1.34 13.74
2008-09-30 26.92 $1.44 18.69
2008-06-30 25.79 $1.39 18.55
2008-03-31 28.70 $1.22 23.52
2007-12-31 30.70 $1.18 26.13
2007-09-30 30.42 $1.10 27.65
2007-06-30 26.72 $1.00 26.85
2007-03-31 27.59 $1.06 26.03
2006-12-31 24.49 $0.91 26.91
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $11.056B $10.119B
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics and other alternate care sites. The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of branded products and Henry Schein private-brand products in stock.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $71.370B 19.28
Align Technology (ALGN) United States $48.443B 106.46
McKesson (MCK) United States $30.927B 11.35
Laboratory Of America Holdings (LH) United States $25.501B 8.61
West Pharmaceutical Services (WST) United States $25.379B 59.38
AmerisourceBergen (ABC) United States $24.842B 14.31
Straumann Holding AG (SAUHF) Switzerland $23.596B 0.00
Cooper (COO) United States $18.425B 31.20
Cardinal Health (CAH) United States $17.412B 10.31
DENTSPLY SIRONA (XRAY) United States $14.424B 31.76
STAAR Surgical (STAA) United States $6.764B 327.80
CONMED (CNMD) United States $3.964B 59.76
SmileDirectClub (SDC) United States $3.774B 0.00
Patterson (PDCO) United States $3.475B 18.25
Merit Medical Systems (MMSI) United States $3.438B 34.30
Atrion (ATRI) United States $1.142B 37.05
Antares Pharma (ATRS) United States $0.746B 49.11
Retractable Technologies (RVP) United States $0.382B 8.58
Invacare (IVC) United States $0.290B 0.00
Milestone Scientific (MLSS) United States $0.146B 0.00
Pro-Dex (PDEX) United States $0.120B 30.28
Lifevantage (LFVN) United States $0.118B 8.63
Biolase (BIOL) United States $0.112B 0.00